Clover Corporation Limited ( (AU:CLV) ) has provided an update.
Clover Corporation Limited has announced a significant financial turnaround for the half-year ended 31 January 2025, reporting a profit after tax of $2.4 million, a substantial increase from a $0.6 million loss in the previous corresponding period. This remarkable improvement is highlighted by a 38% rise in revenue to $37.6 million and a 468% increase in profit from ordinary activities after tax, reflecting the company’s strengthened market position and operational efficiency, which may positively impact stakeholders and industry standing.
More about Clover Corporation Limited
Clover Corporation Limited operates in the health and nutrition industry, focusing on the development and sale of nutritional ingredients and products. The company is known for its specialty in microencapsulation technology, which enhances the stability and delivery of sensitive nutritional compounds, catering to markets such as infant nutrition and functional foods.
YTD Price Performance: -21.11%
Average Trading Volume: 87,268
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: A$58.45M
See more data about CLV stock on TipRanks’ Stock Analysis page.